Panacea Biotec Pharma Limited Extract Export Data — India (DGFT 2022–2026)

Name: Panacea Biotec Pharma Limited Extract Export Records India — #4 Exporter, 72 Shipments, $723.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Extract

India Pharmaceutical Trade Intelligence

$12.1M292 Suppliers109 CountriesHS 30049099

ExportsIndia → PHILIPPINES13.7%India → UNITED ARAB9.8%

#1 Supplier: DABUR INDIA #1 Buyer: REGENCY PHARMA

Panacea Biotec Pharma Limited — Extract Exporter #4 | $723.4K Trade Value | TransData Nexus | TransData Nexus

Panacea Biotec Pharma Limited — Extract Exporter Profile

Indian Pharmaceutical Exporter · #4 for Extract · $723.4K export value · DGFT Verified

Panacea Biotec Pharma Limited is the #4 Indian exporter of Extract with $723.4K in export value and 72 verified shipments. Panacea Biotec Pharma Limited holds a 6.0% market share in Extract exports across 13 countries. The company exports 13 pharmaceutical products worth $23.9M across 9 therapeutic categories.

Panacea Biotec Pharma Limited — Extract Export Profile: Buyers & Destinations

Panacea Biotec Pharma Limited Extract export treemap — buyers and destination countries | TransData Nexus

Where Does Panacea Biotec Pharma Limited Export Extract?

Country	Value	Shipments	Share
JORDAN	$176.3K	12	26.3%
UZBEKISTAN	$99.3K	8	14.8%
TANZANIA	$99.2K	9	14.8%
QATAR	$57.0K	6	8.5%
KAZAKHSTAN	$44.3K	3

Who Are the Top Buyers of Extract from Panacea Biotec Pharma Limited?

Buyer	Country	Value	Orders
JAWEDA INT'L DRUG STORE	JORDAN	$81.3K	7
AL SALIM DRUG STORE	JORDAN	$68.9K	3
LLC SERENE PHARMA	UZBEKISTAN	$54.7K	2
GENERICS & SPECIALITIES LIMITED,	TANZANIA	$46.4K	4
KARIBU PHARMACEUTICALS LTD	ZAMBIA	$43.3K	8
M S GENERICS SPECIALITIES LTD	TANZANIA	$38.3K	2
OOO "CALYX-PHARMA"	UZBEKISTAN	$32.7K	4
M/S. WELLCARE TRADING	QATAR	$29.6K	4
WELLCARE TRADING	QATAR	$27.5K	2
M S TOO CORAL MED KAZAKHSTAN REPUBLIC OF KAZAKHSTANALMATY MICROREGION 2	KAZAKHSTAN	$26.3K	2

Panacea Biotec Pharma Limited supplies Extract to 29 buyers globally. The largest buyer is JAWEDA INT'L DRUG STORE (JORDAN), followed by AL SALIM DRUG STORE (JORDAN) and LLC SERENE PHARMA (UZBEKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Extract Formulations Does Panacea Biotec Pharma Limited Export?

Product Description / Formulation	Value	Shipments
SITCOM TABLETS EACH FILM COATED TABLET CONTAINS EUPHORBIA PROSTRATA DRY EXTRACTETHANOLIC 80% (V/V) (35-70) :1) 100 MG B	$124.6K	11
SITCOM TABLETS EACH FILM COATED TABLET CONTAINS EUPHORBIA PROSTRATA DRY EXTRACTETHANOLIC 80 V V 35 70 1 100 MG B	$70.7K	7
SITCOM TABLETS EACH FILM COATED TABLET CONTAINS EUPHORBIA PROSTRATA DRY EXTRACTETHANOLIC 80% (V/V) (35-70) :1) 100 MG T	$43.8K	3
SITCOM TABLETS EACH FILM COATED TABLET CONTAINS EUPHORBIA PROSTRATA DRY EXTRACTETHANOLIC 80% V/V 35-70 :1 100 MG B	$33.1K	2
SITCOM TABLETS EACH FILM COATED TABLET CONTAINS EUPHORBIA PROSTRATA DRY EXTRACTETHANOLIC 80% V/V 35-70 :1 100 MG T	$29.9K	1
SITCOM TABLETS EACH FILM COATED TABLET CONTAINS EUPHORBIA PROSTRATA DRY EXTRACTETHANOLIC 80% (V/V) (35-70) :1) 100 MG (NOS	$28.7K	3
SITCOMT TABLETS EACH FILM COATED TABLETCONTAINS EUPHORBIA PROSTRATA DRY EXTRACTETHANOLIC 80% V/V 35-70 :1 100 MG	$21.0K	2
SITCOM CREAM EUPHORBIA PROSTRATA DRY EXTRACT ETHANOLIC 80% (V/V) (35-70) :1) CREAM 1% W/W) B/N.74924008 M/D.02/2025 E/D.	$18.0K	1
SITCOM CREAM EUPHORBIA PROSTRATA DRY EXTRACT ETHANOLIC 80% (V/V) (35-70) :1) CREAM 1% W/W) B/N.74924007 M/D.02/2025 E/D.	$17.7K	2
SITCOM TABLETS EACH FILM COATED TABLET CONTAINS EUPHORBIA PROSTRATA DRY EXTRACTETHANOLIC 80% V/V35-70 :1 100MG B/N	$17.5K	2

Panacea Biotec Pharma Limited exports 41 distinct Extract formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SITCOM TABLETS EACH FILM COATED TABLET CONTAINS EUPHORBIA PR with 11 shipments worth $124.6K.

How Does Panacea Biotec Pharma Limited Compare to Nearest Extract Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	DABUR INDIA LIMITED	$1.1M	126	3	$8.6K
4	PANACEA BIOTEC PHARMA LIMITED ★	$723.4K	72	13	$10.0K
6	J B CHEMICALS AND PHARMACEUTICALS LIMITED	$625.8K	101	9	$6.2K
5	INDIAN IMMUNOLOGICALS LIMITED	$600.0K	12	1	$50.0K

Panacea Biotec Pharma Limited ranks #4 among 292 Indian Extract exporters. Average shipment value of $10.0K compared to the market average of $22.5K. The closest competitors by value are DABUR INDIA LIMITED and J B CHEMICALS AND PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Extract Exports?

Port	Shipments	% Share
SAHAR AIR	385	17.9%
SAHAR AIR CARGO ACC (INBOM4)	238	11.1%
Bombay Air	128	6.0%
DELHI AIR	124	5.8%
NHAVA SHEVA SEA (INNSA1)	117	5.4%
DELHI AIR CARGO ACC (INDEL4)	101	4.7%
Delhi Air	82	3.8%
BANGALORE ICD (INWFD6)	74	3.4%

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Extract Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Panacea Biotec. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential delays. These maritime disruptions are particularly concerning for time-sensitive pharmaceutical shipments, as extended transit times and congestion elevate the risk of cold-chain failures for vaccines and biologics. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced uncertainties for Indian exporters. While health products have been exempt from U.S. tariffs, there is growing concern that this exemption may not be permanent. The potential imposition of tariffs on pharmaceutical imports could impact Panacea Biotec's profitability, given the company's significant export volume to the U.S. market. (lemonde.fr)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. This shift presents an opportunity for Panacea Biotec to expand its footprint in the U.S. market, provided it can navigate the evolving regulatory and trade environment effectively.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The recent GMP non-compliance issue at Panacea Biotec's Baddi facility underscores the importance of adhering to stringent EU regulations. Addressing these compliance challenges promptly is essential to maintain and grow the company's presence in European markets.

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency (EMA) enforcing stringent quality standards. For Indian exporters, maintaining compliance with these standards is paramount to ensure uninterrupted market access.

Panacea Biotec's recent GMP non-compliance at its Baddi facility highlights the critical need for robust quality management systems. The company has committed to implementing comprehensive corrective and preventive actions and plans to request a re-inspection to reinstate its GMP certificates. (prysm.fi) Proactive measures in quality assurance will be vital for Panacea Biotec to rebuild trust with regulatory bodies and international clients.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Extract shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Panacea Biotec Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 72 individual customs records matching Panacea Biotec Pharma Limited exporting Extract, covering 41 formulations to 14 countries via 29 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 591+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Extract

Extract

Panacea Biotec Pharma Limited — Extract Exporter Profile

Panacea Biotec Pharma Limited — Extract Export Profile: Buyers & Destinations

Where Does Panacea Biotec Pharma Limited Export Extract?

Who Are the Top Buyers of Extract from Panacea Biotec Pharma Limited?

What Is India's Total Extract Export Value and How Much Does Panacea Biotec Pharma Limited Contribute?

What Is the Average Shipment Value for Panacea Biotec Pharma Limited's Extract Exports?

How Does Panacea Biotec Pharma Limited Compare to Other Indian Extract Exporters?

What Extract Formulations Does Panacea Biotec Pharma Limited Export?

How Does Panacea Biotec Pharma Limited Compare to Nearest Extract Exporters?

Which Indian Ports Ship Extract Exports?

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Extract Exports

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

About Panacea Biotec Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Extract Export Data from Panacea Biotec Pharma Limited

Extract Stats

Company Overview

Top Products by Panacea Biotec Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source